8.65

1.29% 0.11

After Hours: 8.66 0.010 +0.12%

Avita Medical Inc (RCEL)

Overview News Price History Option Chain Financials Why RCEL Down? Discussions Forecast Stock Split

Avita Medical Inc stock is traded at $8.65, with a volume of 176.33K. It is up +1.29% in the last 24 hours and down -30.91% over the past month. Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Previous Close:

$8.54

Open:

$8.7

24h Volume:

176.33K

Relative Volume:

1.26

Market Cap:

$226.78M

Revenue:

$50.14M

Net Income/Loss:

$-35.38M

P/E Ratio:

-6.1786

EPS:

-1.4

Net Cash Flow:

$-39.46M

1W Performance:

-5.36%

1M Performance:

-30.91%

6M Performance:

-15.53%

1Y Performance:

-37.77%

1-Day Range:

$8.55

$8.78

1-Week Range:

$8.53

$9.42

52-Week Range:

$7.51

$18.93

Avita Medical Inc Stock (RCEL) Company Profile

Name

Avita Medical Inc

Sector

Healthcare (1174)

Industry

Medical Devices (160)

Phone

661-568-1317

Address

28159 AVENUE STANFORD, VALENCIA, CA

Employee

207

Twitter

@AvitaMedical

Next Earnings Date

2024-12-07

Latest SEC Filings

RCEL's Discussions on Twitter

Compare RCEL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RCEL Avita Medical Inc	8.65	226.78M	50.14M	-35.38M	-39.46M	-1.40
ABT Abbott Laboratories	113.48	196.83B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	383.42	146.17B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	98.66	145.41B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	88.08	112.94B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	69.78	41.16B	6.60B	4.16B	490.10M	6.93

Avita Medical Inc Stock (RCEL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-24-24	Initiated	D. Boral Capital	Buy
Apr-11-24	Downgrade	BTIG Research	Buy → Neutral
Jun-27-23	Initiated	Cantor Fitzgerald	Overweight
Mar-02-21	Initiated	Piper Sandler	Overweight
Aug-27-20	Initiated	BofA Securities	Buy
Apr-21-20	Initiated	Oppenheimer	Outperform
Mar-03-20	Initiated	BTIG Research	Buy

View All

Avita Medical Inc Stock (RCEL) Latest News

02:57 AM

AVITA Medical's shares sink 19% after another forecast cut - MSN

02:57 AM

Jan 19, 2025

Short Interest in AVITA Medical, Inc. (NASDAQ:RCEL) Rises By 25.9% - MarketBeat

Jan 19, 2025

Barclays PLC Grows Stock Holdings in AVITA Medical, Inc. (NASDAQ:RCEL) - MarketBeat

Jan 19, 2025

Jan 17, 2025

(RCEL) Investment Analysis - Stock Traders Daily

Jan 17, 2025

Why Avita Medical, Cettire, Domino's Pizza, and Star shares are falling today - MSN

Jan 17, 2025

Jan 14, 2025

AVITA Medical’s Growth Struggles Amplify Financial Risks (NASDAQ:RCEL) - Seeking Alpha

Jan 14, 2025

Jan 12, 2025

Investors Burned By AVITA Medical's Sales Miss: I'm Even More Bullish - Seeking Alpha

Jan 12, 2025

Jan 10, 2025

AVITA Medical: A Dip Buy As 2025 Looks Bullish With Cohealyx And RECELL GO Mini - Seeking Alpha

Jan 10, 2025

Lake Street Capital Issues Pessimistic Forecast for AVITA Medical (NASDAQ:RCEL) Stock Price - Defense World

Jan 10, 2025

D. Boral Capital Reiterates Buy Rating for AVITA Medical (NASDAQ:RCEL) - Defense World

Jan 10, 2025

Jan 09, 2025

ASX shares plunge but remain undervalued - Morningstar.com.au

Jan 09, 2025